Michael Myers

Title: Michael Myers - Innovator in Pharmaceutical Composition

Introduction

Michael Myers is a notable inventor based in Broadlands, Virginia. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on sustained release aminopyridine compositions. His research and inventions aim to improve treatment options for various neurological diseases.

Latest Patents

Michael Myers holds a patent for a pharmaceutical composition titled "Sustained release aminopyridine composition." This invention comprises a therapeutically effective amount of aminopyridine dispersed in a release matrix. The composition can be formulated into a stable, sustained-release oral dosage formulation, such as a tablet. Upon administration, it provides a therapeutically effective plasma level of aminopyridine for at least 12 hours, and preferably 24 hours or more. This invention is particularly useful in treating various neurological diseases.

Career Highlights

Michael is currently employed at Alkermes Pharma Ireland Limited, where he continues to develop innovative pharmaceutical solutions. His work has been instrumental in advancing the understanding and treatment of neurological conditions.

Collaborations

Michael collaborates with talented professionals in his field, including Sean Cunningham and Seamus Mulligan. Their combined expertise contributes to the success of their projects and innovations.

Conclusion

Michael Myers is a dedicated inventor whose work in pharmaceutical compositions has the potential to significantly impact the treatment of neurological diseases. His innovative approach and collaboration with skilled colleagues highlight his commitment to advancing medical science.